Pharmacokinetic study is key step on path to expansion into US marketNEW YORK, June 18, 2024 (GLOBE NEWSWIRE) -- Intelligent…
First Quarter Revenue Increased 30.2% and Gross Profit Increased 159.8% from Prior Year Quarter Confirms Strategic Pivot Targeting the U.S.…
MINNEAPOLIS, MN, June 18, 2024 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the “Company” or “FOXO”), today announced…
BOSTON, June 18, 2024 (GLOBE NEWSWIRE) -- Cerevance, a company focused on developing precision novel therapeutics for central nervous system…
NOTE CHANGE IN DATE OF UPDATE CALL TO THURSDAY JUNE 20thCANTON, Mass., June 18, 2024 (GLOBE NEWSWIRE) -- Pressure BioSciences,…
STAMFORD, Conn., June 18, 2024 (GLOBE NEWSWIRE) -- Upswing Health, the surgeon-founded virtual orthopedic care company, today announced a partnership…
FLOW kidney outcomes trial data evaluating efficacy and safety of once-weekly semaglutide 1.0 mg in people with type 2 diabetes1SELECT…
Oak Ridge, TN, June 18, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement…
SOUTH SAN FRANCISCO, Calif., June 18, 2024 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field…
– Phase 1b study will evaluate safety, pharmacokinetic and efficacy endpoints in participants with chronic hepatitis B virus infection with…